These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25799662)

  • 1. [Osteoporosis].
    Uebelhart B; Rizzoli R
    Rev Med Suisse; 2015 Jan; 11(456-457):108-13. PubMed ID: 25799662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future treatments of osteoporosis in men.
    Kaufman JM; Lapauw B; Goemaere S
    Best Pract Res Clin Endocrinol Metab; 2014 Dec; 28(6):871-84. PubMed ID: 25432358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future directions for new medical entities in osteoporosis.
    Ferrari S
    Best Pract Res Clin Endocrinol Metab; 2014 Dec; 28(6):859-70. PubMed ID: 25432357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic targets for osteoporosis.
    Anagnostis P; Gkekas NK; Potoupnis M; Kenanidis E; Tsiridis E; Goulis DG
    Maturitas; 2019 Feb; 120():1-6. PubMed ID: 30583758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone remodeling: new therapeutic approaches].
    Ferrari S
    Rev Med Suisse; 2009 Jun; 5(207):1325-8. PubMed ID: 19626933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological therapy for osteoporosis].
    Nakamura S; Tanaka S
    Clin Calcium; 2014 Jun; 24(6):919-25. PubMed ID: 24870844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Romosozumab for the treatment of osteoporosis.
    Bandeira L; Lewiecki EM; Bilezikian JP
    Expert Opin Biol Ther; 2017 Feb; 17(2):255-263. PubMed ID: 28064540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological agents in management of osteoporosis.
    Tella SH; Gallagher JC
    Eur J Clin Pharmacol; 2014 Nov; 70(11):1291-301. PubMed ID: 25204309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Established and forthcoming drugs for the treatment of osteoporosis.
    Lems WF; Geusens P
    Curr Opin Rheumatol; 2014 May; 26(3):245-51. PubMed ID: 24625372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic innovation in osteoporosis (antisclerostin antibody and denosumab)].
    Quemerais-Durieu MA; Kerlan V; Chabre O
    Ann Endocrinol (Paris); 2011 Oct; 72 Suppl 1():S15-22. PubMed ID: 22008272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Status of drug development for the prevention and treatment of osteoporosis.
    Schwarz P; Jørgensen NR; Abrahamsen B
    Expert Opin Drug Discov; 2014 Mar; 9(3):245-53. PubMed ID: 24490672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of romosozumab and its potential in the management of osteoporosis.
    Lim SY; Bolster MB
    Drug Des Devel Ther; 2017; 11():1221-1231. PubMed ID: 28458516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel strategies for the development of anabolic agents for treatment of osteoporosis].
    Saeki M; Egusa H
    Nihon Yakurigaku Zasshi; 2014 Dec; 144(6):277-80. PubMed ID: 25492363
    [No Abstract]   [Full Text] [Related]  

  • 15. [Symptomatic hypocalcaemia on denosumab use].
    Baptista Lopes V; Robbrecht D; van Thiel S; van Guldener C
    Ned Tijdschr Geneeskd; 2013; 157(29):A6159. PubMed ID: 23859106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Innovations in the treatment of osteoporosis].
    Tsourdi E; Hofbauer LC
    Dtsch Med Wochenschr; 2011 Dec; 136(48):2458-60. PubMed ID: 22109575
    [No Abstract]   [Full Text] [Related]  

  • 17. Short-term and long-term effects of osteoporosis therapies.
    Reid IR
    Nat Rev Endocrinol; 2015 Jul; 11(7):418-28. PubMed ID: 25963272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Osteoporosis].
    Uebelhart B; Ferrari S
    Rev Med Suisse; 2017 Jan; 13(544-545):88-90. PubMed ID: 28703545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Romosozumab: from basic to clinical aspects.
    Minisola S
    Expert Opin Biol Ther; 2014 Sep; 14(9):1225-8. PubMed ID: 24835636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective.
    Parthan A; Kruse M; Agodoa I; Silverman S; Orwoll E
    Bone; 2014 Feb; 59():105-13. PubMed ID: 24231131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.